Bonesupport Holding AB (publ) (BOEUF)
USD 32.55
(-2.11%)
USD 32.55
(-2.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 143.63 Million SEK | 39.6% |
| 2022 | 102.89 Million SEK | 31.55% |
| 2021 | 78.21 Million SEK | 17.94% |
| 2020 | 66.31 Million SEK | -7.92% |
| 2019 | 72.02 Million SEK | 51.28% |
| 2018 | 47.61 Million SEK | -67.37% |
| 2017 | 145.89 Million SEK | -5.57% |
| 2016 | 154.5 Million SEK | 69.22% |
| 2015 | 91.3 Million SEK | 2.43% |
| 2014 | 89.13 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 116.84 Million SEK | -5.16% |
| 2024 Q1 | 158.5 Million SEK | 10.35% |
| 2024 Q2 | 123.21 Million SEK | -22.27% |
| 2023 Q3 | 101.3 Million SEK | 7.95% |
| 2023 Q1 | 104.22 Million SEK | 1.3% |
| 2023 Q2 | 93.84 Million SEK | -9.96% |
| 2023 FY | 143.63 Million SEK | 39.6% |
| 2023 Q4 | 143.63 Million SEK | 41.79% |
| 2022 Q1 | 79.47 Million SEK | 1.61% |
| 2022 Q3 | 86.3 Million SEK | 12.45% |
| 2022 FY | 102.89 Million SEK | 31.55% |
| 2022 Q4 | 102.89 Million SEK | 19.22% |
| 2022 Q2 | 76.74 Million SEK | -3.43% |
| 2021 Q3 | 57.75 Million SEK | -2.64% |
| 2021 FY | 78.21 Million SEK | 17.94% |
| 2021 Q2 | 59.32 Million SEK | -7.22% |
| 2021 Q4 | 78.21 Million SEK | 35.42% |
| 2021 Q1 | 63.94 Million SEK | -3.58% |
| 2020 Q3 | 58.32 Million SEK | 7.85% |
| 2020 Q4 | 66.31 Million SEK | 13.71% |
| 2020 Q1 | 66.41 Million SEK | -7.79% |
| 2020 FY | 66.31 Million SEK | -7.92% |
| 2020 Q2 | 54.07 Million SEK | -18.57% |
| 2019 Q4 | 72.02 Million SEK | 3.99% |
| 2019 FY | 72.02 Million SEK | 51.28% |
| 2019 Q3 | 69.25 Million SEK | -1.38% |
| 2019 Q2 | 70.22 Million SEK | 10.68% |
| 2019 Q1 | 63.44 Million SEK | 33.26% |
| 2018 Q1 | 45.95 Million SEK | -68.5% |
| 2018 Q2 | 42.4 Million SEK | -7.74% |
| 2018 Q3 | 44.34 Million SEK | 4.57% |
| 2018 Q4 | 47.61 Million SEK | 7.37% |
| 2018 FY | 47.61 Million SEK | -67.37% |
| 2017 FY | 145.89 Million SEK | -5.57% |
| 2017 Q1 | 148.08 Million SEK | -4.16% |
| 2017 Q2 | 148.96 Million SEK | 0.59% |
| 2017 Q3 | 137.95 Million SEK | -7.39% |
| 2017 Q4 | 145.89 Million SEK | 5.76% |
| 2016 FY | 154.5 Million SEK | 69.22% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q4 | 154.5 Million SEK | 0.0% |
| 2015 FY | 91.3 Million SEK | 2.43% |
| 2014 FY | 89.13 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -6012.704% |
| Ansell Limited | 1.32 Billion USD | 89.199% |
| Ansell Limited | 1.33 Billion USD | 89.22% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -13.694% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -15129.354% |
| Psykey, Inc. | 2.47 Million USD | -5705.897% |
| ConvaTec Group Plc | 2.01 Billion USD | 92.883% |
| ConvaTec Group Plc | 2.02 Billion USD | 92.893% |
| Encision Inc. | 1.98 Million USD | -7139.986% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -4624.223% |
| Innovative MedTech Inc. | 6.13 Million USD | -2241.364% |
| LifePoint, Inc. | 2.45 Million USD | -5752.857% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -1310.854% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -4124.676% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -4624.465% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -18402.336% |
| SmileDirectClub, Inc. | 982.26 Million USD | 85.377% |
| Sector 10, Inc. | 9.84 Million USD | -1358.941% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 89.405% |
| SheerVision, Inc. | 1.43 Million USD | -9934.84% |
| United Health Products, Inc. | 1.99 Million USD | -7086.014% |
| Vasamed, Inc. | 1 Million USD | -14188.173% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -3679.69% |
| Yubo International Biotech Limited | 2.91 Million USD | -4829.401% |